P-81  WITHDRAWN

P-82  Phase II Clinical Trial of S-1/Paclitaxel and Cisplatin Triplet Combination Chemotherapy in Patients with Advanced Gastric Cancer

Jin Young Kim¹, Young Rok Do¹, Keon Uk Park¹, Hong Suk Song¹, Won Sik Lee², Hyun Mo Rhoo³

¹Department of Hemato-oncology, Dong San Medical Center, Korea, ²Fatima General Hospital, ³Daegu Catholic University Hospital

P-83  CHARACTERISTICS OF PATIENTS WITH EARLY GASTRIC CANCER WHO HAD UNDERGONE SURGERY IN TWO INSTITITES

Kyung Tae Park¹, Jin Ho Baek², Do-Ha Kim³, Gyu Yeol Kim⁴

¹Department of Hematology and Oncology, Sungkyunkwan University, Korea, ²Department of Hematology and Oncology, University Hopital, University of Ulsan College of Medicine, Korea, ³Department of Gastroentelogy, Ulsan University Hospital, University of Ulsan College of Medicine, Korea, ⁴Department of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Korea

P-84  Clinical outcome of advanced gastric cancer patients with bone marrow metastases

Sang-Cheol Lee, Kyung Ha Kim, Hee Sook Park, Jong-Ho Won, Han Jo Kim, Se-Hyung Kim, Hyung Jung Kim, Sang Byung Bae, Chan Kyu Kim, Kyu-Taek Lee, Sung Kyu Park, Dae Sik Hong

Hematology & Oncology, Soonchunhyang University Hospital, Republic of Korea

P-85  Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer with curative resection

Seok Yun Kang¹, Hyun Woo Lee¹, Seoung Hyun Jeong¹, Jin-Hyuk Choi¹, Young-Kwan Cho², Sang Wook Han², Jae Ho Han³

¹Department of Hematology-Oncology, Ajou University School of Medicine, Korea, ²Department of Surgery, ³Department of Pathology

P-86  A randomized Phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with advanced gastric cancer

Sun Jin Sym¹, Se Hoon Park², Jinny Park¹, Eun Kyung Cho¹, Woon Ki Lee³, Min Chung³, Dong Bok Shin¹, Jea Hoon Lee¹

¹Internal Medicine, Gachon University Gil Hospital, Korea, ²Division of Hematology/Oncology, Deparment of Medicine, Sungkyunkwan University Samsung Medical Center, ³Deparment of Surgery, Gachon University Gil Hospital, Korea

P-87  Capecitabine plus oxaliplatin versus 5-fluorouracil/folinic acid plus oxaliplatin as first-line therapy in adjuvant colon cancer

Safa Najafi¹, Ghasem Janbabaee², Mehrdad Paiandeh³, Mohamadhossein Shojamorady¹, Samaneh Erfani²

¹Department of Oncology, Iranian Center for Breast Cancer, Iran, ²Department of Oncology, Mazandaran University, Iran., ³Department of Oncology, Kermanshah University, Iran

 YIA  P-88  Safety and efficacy analysis of bevacizumab combined chemotherapy for metastatic colorectal cancer patients (HGCSG0801)

Susumu Sogabe¹, Satoshi Yuki¹, Ichiro Iwanaga¹, Satoshi Takeuchi², Michio Nakamura³, Hideyuki Hayashi⁴, Kazuteru Hatanaka⁴, Masatoshi Takano⁵, Syuichi Muto⁶, Kanji Kato⁷, Kencho Miyashita⁸, Yutaka Watanabe⁹, Yuji Tsukioka¹⁰, Ayumu Hosokawa¹¹, Takashi Kato¹², Takashi Meguro¹², Takuto Miyagishima¹³, Takaya Kusumi¹⁴, Masao Hosokawa¹⁴, Masahiro Asaka¹, Yoshito Komatsu¹⁵

¹Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Japan, ²Department of Medical Oncology, Hokkaido University Graduate School of Medicine, Japan, ³Department of Gastroenterology, Sapporo City General Hospital, Japan, ⁴Department of Gastroenterology, Hakodate Municipal Hospital, Japan, ⁵Department of Gastroenterology, Sapporo Hokuyu Hospital, Japan, ⁶Department of Gastroenterology, Tomakomai City Hospital, Japan, ⁷Department of Internal Medicine, Wakkanai City Hospital, Japan, ⁸Department of Internal Medicine and Gastroenterology, Abashiri Kosei General Hospital, Japan, ⁹Department of Internal Medicine, Hakodate Central General Hospital, Japan, ¹⁰Department of Surgery, Takaoka City Hospital, Japan, ¹¹Department of Gastroenterology and Hematology, Toyama University Graduate School of Medicine, Japan, ¹²Department of Internal Medicine, Hokkaido Gastroenterology Hospital, Japan, ¹³Department of Internal Medicine,Kushiro Rosai Hospital, Japan, ¹⁴Department of Surgical Oncology, Keiyukai Sapporo Hospital, Japan, ¹⁵Department of Cancer Center, Hokkaido University Hospital, Japan

P-89  Phase II study of preoperative concurrent chemoradiotherapy (CRT) with irinotecan plus TS-1 in locally advanced rectal cancer

Soojung Hong¹, Sang Joon Shin¹, Nam Kyu Kim², Ki Chang Keum³, Ho Geun Kim⁴, Jun Seok Im⁵, Hye Jin Choi¹, Seung Hyuk Baik², Jae Hee Choen¹, Sun Young Rha¹, Jae Kyung Roh¹, Hei-Cheul Jeung¹, Hyun Cheol Chung¹, Joong Bae Ahn¹

¹Department of Internal Medicine, Yonsei Universtiy College of Medicine, Korea, ²Department of Surgery, Yonsei Universtiy College of Medicine, Korea, ³Department of Radiation Oncology, Yonsei Universtiy College of Medicine, Korea, ⁴Department of Pathology, Yonsei Universtiy College of Medicine, Korea, ⁵Department of Diagnostic Radiology, Yonsei Universtiy College of Medicine, Korea

P-90  Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer

Minkyu Jung¹, Sang Joon Shin¹, Jae Heon Jeong¹, Young Suk Park², Kyung Hee Lee³, Byoung Yong Shim⁴, Tae Won Kim⁵, Do Youn Oh⁶, Myung Ah Lee⁷, Yong Tai Kim⁸, Yeul Hong Kim⁹, Dae Young Zang¹⁰, Jae Kyung Roh¹, Joong Bae Ahn¹

¹Department of Internval Medicine, Yonsei University College of Medicine, Korea, ²Samsung Medical Center, ³Yeungnam University College of Medicine, ⁴St. Vincent's Hospital, ⁵Asan Medical Cente, ⁶Seoul National University Hospital, ⁷St Mary's Hospital, ⁸National Health Insurance Corporation Ilsan Hospital, ⁹Korea University Anam Hospital, ¹⁰Hallym University College of Medicine

P-91  UGT1A1*6 and *28 in Japanese colorectal cancer patients treated with irinotecan-based chemotherapy

Ichiro Iwanaga¹, Yoshito Komatsu¹, Takahide Sasaki¹, Hiroshi Nakatsumi¹, Susumu Sogabe¹, Satoshi Yuki¹, Takaya Kusumi², Masao Hosokawa², Masahiro Asaka¹

¹Department of Gastroenterology, Hokkaido University, Japan, ²Keiyuhkai Sapporo Hospital

P-92  Capability of FDG-PET in Detecting Malignant Tumors in Hyperglycemic Patients

Shigeaki Higashiyama, Joji Kawabe, Atsushi Yoshida, Kohei Kotani, Hiroyuki Tsushima, Etsushi Kawamura, Susumu Shiomi

Department of Nuclear Medicine, Osaka City University, Graduate School of Medicine, Japan

P-93  A Phase II Study of Combination Chemotherapy with Gemcitabine, 5-Fluorouracil, and Cisplatin(GFP) for Advanced Pancreatic Cancer

Hyo Rak Lee, Sungkyun Cho, Sung Rok Kim

Department of Hemato-oncology, Inje University, Sanggye-paik Hospital, Republic of Korea

↑ Page Top